Allurion Technologies Inc.

ALUR | NYSE

Price Alert Chart Builder DCF Calculator

$0.80

+$0.07 (+9.57%)

Mar 19, 2026, 3:08 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+9.57%

(1D)

Rating

Updated: Feb 23, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $6.21M

1D Range

0.74 0.86

52W Range

0.23 4.18

Valuation (TTM)

PE -0.07

PB -0.07

EV/EBITDA -0.99

Valuation (NTM)

Forward PE N/A

Forward PEG N/A

Price Target $3

Cash Flow

FCF Yield N/A

SBC Adj. FCF Yield N/A

SBC Impact -5.0%

Margins

Gross Margin 61.0%

Operating Margin -238.1%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y N/A | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA -238.6%

ROE 58.8%

ROIC -586.1%

Financial Health

Net Debt

$26.58M

Current Ratio 1.26

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intraga...

Sector Healthcare

Industry Medical - Devices

Employees 134

IPO Date Mar 28, 2021

Website www.allurion.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Mar 25, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞